UBS Group AG is not a strong buy for a beginner, long-term investor at this moment. While the company has shown improvements in net income and EPS, the negative revenue growth, neutral trading sentiment, and lack of strong positive catalysts make it less compelling. Additionally, the absence of strong trading signals and mixed analyst ratings suggest a wait-and-see approach is more prudent.
The MACD is positive but contracting, RSI is neutral at 34.904, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 41.13), with resistance at R1: 44.044.

Gross margin also improved by 10.98%.
UBS faces regulatory pressure to build $20 billion in additional capital buffers, which could strain resources. Analysts have mixed ratings, with some downgrades and reduced price targets.
In Q4 2025, UBS reported a revenue decline of 6.09% YoY to $18.33 billion. However, net income rose by 55.71% YoY to $1.199 billion, and EPS increased by 60.87% YoY to 0.37. Gross margin improved to 66.42%, up 10.98%.
Recent analyst ratings are mixed. Barclays upgraded UBS to Equal Weight with a CHF 34 price target, while Morgan Stanley raised its target to CHF 32 but maintained an Underweight rating. Citi raised its target to CHF 33 but kept a Neutral rating. Goldman Sachs downgraded UBS to Neutral with a reduced price target of CHF 38.